That study included serum creatinine, urinary albumin/creatinine ratio (ACR), age, sex, diabetes duration, follow-up time, HbA1c, and prior cardiovascular disease information to predict final eGFR with an r2 of 0.745 (p < 10−16). This evidence concerns the gene ALB and diabetes mellitus.